Clinical Trials
2
Active:0
Completed:2
Trial Phases
1 Phases
Phase 1:2
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials
Phase 1
2 (100.0%)An Escalating Dose Study to Evaluate the Safety, Tolerability and Pharmacokinetics of LNK 754 in Elderly Volunteers and in Subjects With Mild Alzheimer's Disease
- First Posted Date
- 2009-11-16
- Last Posted Date
- 2011-03-15
- Lead Sponsor
- Link Medicine Corporation
- Target Recruit Count
- 110
- Registration Number
- NCT01013610
- Locations
- 🇺🇸
Dedicated Phase I, Phoenix, Arizona, United States
🇺🇸Collaborative Neuroscience Network, Long Beach, California, United States
🇺🇸Elite Research Insitute, Miami, Florida, United States
A Double-Blind, Placebo Controlled, Single, Escalating Dose Study to Evaluate the Preliminary Pharmacokinetics, Safety and Tolerability of LNK-754 in Healthy Elderly Volunteers
Phase 1
Completed
- Conditions
- Healthy Elderly Volunteers
- First Posted Date
- 2009-05-18
- Last Posted Date
- 2009-09-10
- Lead Sponsor
- Link Medicine Corporation
- Target Recruit Count
- 40
- Registration Number
- NCT00903253
- Locations
- 🇺🇸
CEDRA Clinical Research, Austin, Texas, United States
News
No news found